Table 2. Prevalence of SUDDs by Geographic Region Among 15 637 Transgender and 56 911 Cisgender Adults, 2017a.
| SUDD | No. (%) | Bivariate comparisonsb | ||
|---|---|---|---|---|
| Transgender (n = 15 637) | Cisgender (n = 46 911) | χ2 | P value | |
| Northeast | ||||
| Total adults, No. | 1963 | 5889 | ||
| Nicotine | 352 (17.9) | 281 (4.8) | 344.0 | <.001 |
| Alcohol | 65 (3.3) | 72 (1.2) | 37.5 | <.001 |
| Cannabis | 62 (3.2) | 33 (0.6) | 83.1 | <.001 |
| Cocaine | 19 (1.0) | 12 (0.2) | 21.9 | <.001 |
| Opioid | 32 (1.6) | 32 (0.5) | 21.5 | <.001 |
| Another drugc | 49 (2.5) | 36 (0.6) | 48.9 | <.001 |
| South | ||||
| Total adults, No. | 6842 | 19 446 | ||
| Nicotine | 1103 (17.0) | 1165 (6.0) | 740.4 | <.001 |
| Alcohol | 146 (2.3) | 157 (0.8) | 87.9 | <.001 |
| Cannabis | 103 (1.6) | 59 (0.3) | 129.4 | <.001 |
| Cocained | >24 (>0.4) | >24 (>0.1) | NA | <.001 |
| Opioid | 89 (1.4) | 92 (0.5) | 56.8 | <.001 |
| Another drugc | 110 (1.7) | 79 (0.4) | 111.9 | <.001 |
| Midwest | ||||
| Total adults, No. | 3760 | 11 280 | ||
| Nicotine | 673 (17.9) | 695 (6.2) | 469.9 | <.001 |
| Alcohol | 118 (3.10) | 112 (1.0) | 86.2 | <.001 |
| Cannabis | 94 (2.5) | 49 (0.4) | 127.8 | <.001 |
| Cocaine | 27 (0.7) | 12 (0.1) | 40.8 | <.001 |
| Opioid | 51 (1.4) | 42 (0.4) | 44.4 | <.001 |
| Another drugc | 58 (1.5) | 35 (0.3) | 69.7 | <.001 |
| West | ||||
| Total adults, No. | 3432 | 10 296 | ||
| Nicotine | 466 (0.1) | 410 (4.0) | 396.8 | <.001 |
| Alcohol | 72 (0.2) | 97 (0.9) | 28.3 | <.001 |
| Cannabis | 62 (0.2) | 45 (0.4) | 62.4 | <.001 |
| Cocained | <11 (<0.3) | <11 (<0.1) | NA | .01 |
| Opioid | 33 (0.1) | 41 (0.4) | 15.2 | <.001 |
| Another drugc | 48 (0.1) | 33 (0.3) | 51.0 | <.001 |
Abbreviation: SUDD, substance use disorder diagnosis.
Hawaii and Alaska are included in the West according to the US Census. US territories (eg, Puerto Rico and Guam) are not included in US Census regions; thus the approximately 100 individuals without an assigned census region were included in the South.
Bivariate comparisons are between transgender and cisgender people in each region of the United States. Comparisons were also made in the frequency of each SUDD among transgender individuals across regions and among cisgender people across regions. Among transgender people, significant within group differences (P < .05) were observed for all SUDDs across regions with the exception of cocaine (P = .18). Among cisgender people, significant within group differences (P < .05) were observed for all SUDDs across regions with the exception of cocaine (P = .21) and opioid (P = .31) SUDDs.
Another drug SUDD includes hallucinogens, sedatives, stimulants, and the diagnosis of other SUD not otherwise specified.
Exact values are not reported to prevent back calculation and protect the confidentiality of individuals.